MOTS-C 10 mg

Dragon Pharma MOTS-C

MOTS-C 10 mg represents a groundbreaking advancement in metabolic peptide therapy—the first mitochondrial-derived peptide available for athletic and bodybuilding applications. This revolutionary 16-amino acid peptide, encoded within the mitochondrial genome rather than nuclear DNA, represents a paradigm shift in how we approach metabolic optimization, endurance enhancement, and age-related decline. Each vial contains 10 mg of pharmaceutical-grade MOTS-C, synthesized in Dragon Pharma's EU-certified facilities using advanced peptide synthesis technology that preserves the unique structural integrity required for mitochondrial signaling.

MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA-c) operates through mechanisms fundamentally different from traditional peptides. Unlike growth factors or secretagogues that work through cell surface receptors, MOTS-C translocates to the nucleus under metabolic stress where it regulates nuclear gene expression through interaction with the antioxidant response pathway. This unique action allows it to reprogram cellular metabolism, enhance insulin sensitivity, increase glucose uptake into skeletal muscle, and promote mitochondrial biogenesis—all while protecting against metabolic stressors that accumulate during intense training and calorie restriction.

The scientific significance of MOTS-C cannot be overstated. As a mitochondrial-encoded peptide, it represents an evolutionary conserved mechanism for metabolic adaptation that links cellular energy status with gene expression. In practical terms for athletes, this means enhanced endurance through improved fatty acid oxidation, superior body composition through AMPK activation (the cellular "energy sensor"), reduced systemic inflammation via NRF2 pathway modulation, and protection against age-related metabolic decline. When compared to traditional metabolic agents like Clenbuterol, MOTS-C offers sustainable metabolic enhancement without beta-2 receptor downregulation or cardiovascular stress.

Dragon Pharma's formulation preserves the native peptide sequence (MRWQEMGYIFYPRKLR) with critical post-translational modifications intact. The lyophilized powder ensures optimal stability, easily reconstituted with bacteriostatic water for precise subcutaneous administration. For bodybuilders, MOTS-C offers particular advantages during cutting phases: it promotes stubborn fat loss (especially visceral abdominal fat) while preserving lean mass, enhances insulin sensitivity to improve nutrient partitioning, and increases exercise capacity to maintain training intensity in calorie deficit. When stacked with androgenic compounds like Trenbolone 50 or Masteron 100, MOTS-C creates a powerful synergy—the androgens provide anabolic signaling while MOTS-C optimizes the metabolic environment for maximal results.

Key Benefits:

• Metabolic Reprogramming: Enhances insulin sensitivity and glucose metabolism through nuclear gene regulation, turning muscles into more efficient energy-processing engines for improved body composition.
• Mitochondrial Biogenesis: Stimulates creation of new mitochondria and improves function of existing ones, increasing cellular energy production and endurance capacity for longer, more intense training sessions.
• AMPK Pathway Activation: Activates the cellular "energy sensor" that promotes fat burning, glucose uptake, and mitochondrial health while inhibiting mTOR to mimic beneficial effects of exercise and calorie restriction.
• Muscle Preservation During Cutting: Shifts fuel utilization toward fatty acids while sparing glucose and amino acids, protecting lean mass during calorie deficit and preventing catabolism.
• Systemic Anti-Aging Effects: Reduces oxidative stress, decreases inflammatory markers, and enhances cellular resilience through NRF2 pathway modulation, supporting long-term health and training longevity.

Each 2 mL vial contains 10 mg of pharmaceutical-grade MOTS-C peptide, manufactured under strict quality control standards in Dragon Pharma's certified European facilities using solid-phase peptide synthesis with HPLC purification to >98% purity.

Product Specifications

Usage Guidelines

MOTS-C is administered via subcutaneous injection. Reconstitute the 10 mg vial with 1-2 mL of bacteriostatic water. Due to its short half-life but prolonged effects, the optimal protocol is split dosing: 2.5-5 mg administered 2-3 times weekly (e.g., Monday/Thursday or Monday/Wednesday/Friday). Injection sites include abdominal subcutaneous tissue or outer thigh. Use insulin syringes (0.3cc or 0.5cc) for precise dosing. Timing relative to meals isn't critical, but many users prefer morning administration to leverage increased metabolic activity throughout the day. Effects accumulate over weeks rather than hours—consistency is more important than timing.

• Beginner Cycle (8 weeks): 5 mg weekly (2.5 mg twice weekly) for metabolic optimization and mild body recomposition. Ideal when using compounds like Anavar 10 or during maintenance phases. Can be stacked with GW501516 for enhanced endurance and fat oxidation.
• Intermediate Cycle (10 weeks): 7.5 mg weekly (2.5 mg three times weekly) for significant fat loss and endurance enhancement. Effective alongside cutting compounds like Winstrol 10 or Primobolan 100 to preserve muscle during aggressive cuts.
• Advanced Cycle (12 weeks): 10 mg weekly (5 mg twice weekly) for maximum metabolic reprogramming and competition preparation. Often stacked with Trenbolone 100 for extreme conditioning or Testabol 400 for mass-preserving cuts with maintained performance.

Metabolic Optimization Protocol:

For insulin resistance or metabolic syndrome concerns: 10 mg weekly for 12 weeks, then 5 mg weekly maintenance. Monitor fasting glucose and HbA1c improvements. For endurance athletes: Time larger doses (5 mg) 2-3 hours before endurance sessions. For body recomposition: Combine with timed carbohydrate intake—MOTS-C enhances glucose disposal, making post-workout nutrition more efficient. When using alongside T3 for cutting, MOTS-C may allow lower T3 doses due to enhanced metabolic efficiency.

Cycling & Long-Term Use:

MOTS-C doesn't cause receptor desensitization and can be used continuously. However, 12-week cycles followed by 4-week breaks help assess baseline improvements. During breaks, metabolic enhancements typically persist. For year-round metabolic support, consider alternating with other insulin-sensitizing agents like Metformin or AOD-9604. MOTS-C pairs exceptionally well with NAD+ precursors for comprehensive mitochondrial support.

Storage Instructions

Unreconstituted: Store lyophilized MOTS-C vials at -20°C (-4°F) for long-term stability (up to 24 months). For short-term storage (up to 30 days), refrigeration at 2-8°C (36-46°F) is acceptable. The mitochondrial-derived structure is more sensitive to degradation than nuclear-encoded peptides—avoid temperature fluctuations and never store at room temperature for extended periods.

Reconstituted: After mixing with bacteriostatic water, store immediately in refrigerator at 2-8°C (36-46°F). Use within 7 days for maximum potency—MOTS-C has demonstrated stability concerns in solution longer than most peptides. Draw doses into syringes immediately after reconstitution if planning multiple injections from the same vial.

Critical Handling Notes: Protect from light exposure at all stages using amber vials or aluminum foil. Avoid repeated freeze-thaw cycles of powder form. Allow frozen vials to reach refrigerator temperature before reconstitution to prevent condensation. Use alcohol swabs on vial tops before each puncture. Gently swirl (never vortex) to dissolve powder completely without introducing air bubbles.